Display Settings:

Format

Send to:

Choose Destination

    J Psychiatry Neurosci. 1993 Jul;18(4):178-88.

    Neurobiological investigations into the role of cholecystokinin in panic disorder.

    Bradwejn J.

    Department of Psychiatry, McGill University, St. Mary's Hospital, Montreal, Quebec, Canada.

    Cholecystokinin (CCK) is a neurotransmitter found in high density in the brains of mammals. Microiontophoretic studies showing that benzodiazepines selectively antagonized CCK-induced excitation of rat hippocampal neurons have led to the hypothesis that CCK is an anxiogenic peptide. The hypothesis was supported by demonstrations that CCK-tetrapeptide (CCK4) induces panic attacks in humans. This paper reviews phases of investigations which studied the validity of CCK4 as a panicogenic agent and research strategies for the study of panic disorder using CCK4 as an investigative tool.

    PMID: 8104032 [PubMed - indexed for MEDLINE]

    PMCID: PMC1188527

    Supplemental Content

    Click here to read

    Patient drug information

    • Imipramine (Tofranil®, Tofranil® PM)

      Imipramine tablets and capsules are used to treat depression. Imipramine tablets are also used to prevent bedwetting in children. Imipramine is in a class of medications called tricyclic antidepressants. It treats depres...